DOCSLIB.ORG

(12) United States Patent (10) Patent No.: US 7,972,785 B2 Hsieh Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) United States Patent (10) Patent No.: US 7,972,785 B2 Hsieh Et Al US00797 2785B2 (12) United States Patent (10) Patent No.: US 7,972,785 B2 Hsieh et al. (45) Date of Patent: Jul. 5, 2011 (54) BIOMARKERS FOR LIVER FIBROTIC Yi-Chao, Hsu, et al., “Increases in fibrosis-related gene transcripts in INJURY livers of dimethylnitrosamine-intoxicated rats.” J. Biomed Sci. 11:408-417 (2004). Shackel, Nicholas A. et al., “Gene array analysis and the liver.” (75) Inventors: Hui-Chu Hsieh, Changhua (TW); Hepatology, 36(6):1313-1325 (2002). Tzu-Ling Tseng, Chiayi (TW); Li-Jen Utsunomiya, Tohru, et al., “A gene-expression signature can quantify Su, Chiayi (TW); Chi-Ying Huang, the degree of hepatic fibrosis in the rat.” Journal of Hepatology, 41:399-406 (2004). Taipei (TW); Shih-Lan Hsu, Taipei Imaoka, Susumu, et al., “Localization of rat cytochrome P450 in (TW) various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs.” Drug Metab. (73) Assignees: Industrial Technology Research Pharmacokinet, 2006)478-484 (2005). Institute (ITRI), Hsinchu (TW); Wong, V. S., et al., "Serum hyaluronic acid is a useful marker of liver National Health Research Institutes fibrosis in chronic hepatitis C virus infection.” Journal of viral Hepa titis, 5:187-192 (1998). (NHRI), Miaoli County (TW) Ala-Kokko, L., et al., “Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat.” (*) Notice: Subject to any disclaimer, the term of this Biochem. J. 244:75-79 (1987). patent is extended or adjusted under 35 Arthur, M.J.P. et al., “Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis,” J. Gastroenterol. Hepatol. 13 U.S.C. 154(b) by 326 days. (Suppl.):S33-38 (1998). Bataller, R. and Brenner, D.A., “Liver fibrosis.' J. Clin. Invest. (21) Appl. No.: 11/656,389 115(2):209-218 (2005). Bauer, M. and Schuppan, D., “TGFB1 in liver fibrosis: time to change (22) Filed: Jan. 23, 2007 paradigms?.” FEBS Letts. 502:1-3 (2001). Benyon, R.C. and Arthur, M.J., “Extracellular matrix degradation (65) Prior Publication Data and the role of hepatic stellate cells.” Semin. Liver Dis. 21(3):373-84 (2001). US 2007/O184476A1 Aug. 9, 2007 Day, C.P. “Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?” Gut 50:585-588 (2002). DeSouza, L., et al., “Search for cancer markers from endometrial Related U.S. Application Data tissues using differentially labeled tags iTRAQ and cICAT with mul (60) Provisional application No. 60/761,959, filed on Jan. tidimensional liquid chromatography and tandem mass spectrom etry,” J. Proteome Res.4(2):377-386 (2005). 24, 2006. Dooley, S., et al., “Transforming growth factor f3 signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that (51) Int. Cl. is abrogated during in vitro progression to myofibroblasts. TGFB CI2O I/68 (2006.01) signal transduction during transdifferentiation of hepatic stellate GOIN33/53 (2006.01) cells.” FEBS Letts. 502:4-10 (2001). Friedman, S.L., “Liver fibrosis—from bench to bedside.” J. Hepatol. (52) U.S. Cl. ........................................... 435/6: 435/7.92 38 (Suppl. 1):S38-53 (2003). (58) Field of Classification Search ........................ None Friedman, S.L., “Molecular regulation of hepatic fibrosis, an inte See application file for complete search history. grated cellular response to tissue injury.” J. Biol. Chem. 275(4):2247 2250 (2000). (56) References Cited Friedman, S.L., “Seminars in medicine of the Beth Israel Hospital, Boston: The cellular basis of hepatic fibrosis—Mechanisms and treatment strategies.” N. Engl. J. Med. 328(25): 1828-1835 (1993). U.S. PATENT DOCUMENTS George, J., et al., “Dimethylnitrosamine-induced liver injury in rats: 6,156,501 A 12/2000 McGallet al. the early deposition of collagen.” Toxicol. 156: 129-138 (2001). 2006/0246489 A1* 11/2006 Svetlov et al. .................... 435/6 Gressner, A.M., et al., “Roles of TGF-B in hepatic fibrosis.” Front. Biosci. 7:d793-807 (2002). FOREIGN PATENT DOCUMENTS EP 1 150 123 A1 10, 2001 (Continued) OTHER PUBLICATIONS Primary Examiner — Sharon Wen (74) Attorney, Agent, or Firm — Finnegan, Henderson, The Merck Manuals Online Medical Library, online). Whitehouse Farabow, Garrett & Dunner LLP Station, NJ: Merck Research Laboratories, 2007. retrieved on Apr. 7, 2009). Retrieved from the Internet: < URL: http://www.merck.com/ (57) ABSTRACT mmpe/print/sec()3/ch026/ch026b.html>. Fibrosis, pp. 1-3.* The present invention provides a method for detecting liver Afdhal Clinical Chemistry 2004, 50: 1299-1300.* fibrotic injury, including fibrosis and/or cirrhosis, by assaying Bast, Jr. et al. Clinical Cancer Research, 2005, vol. 11, pp. 6103 6108. biological samples for differential expression of at least one LaBaer et al. Journal of Proteome Research, 2005, vol. 4, pp. 1053 gene encoding a protein chosen from SEQID NO: 1-SEQID 1059. NO: 63 and human orthologs thereof, wherein differential Baker Nature Biotechnology, 2005, vol. 23, pp. 297-304.* expression of at least one gene Suggests the presence of liver Honda et al. Journal of Autoimmunity 2005, 25:133-140.* fibrosis or cirrhosis. The invention also provides a kit con Ala-Kokko, Leena, et al., “Gene expression of type I, III and IV taining nucleic acid probes or antibodies for detecting liver collagens in hepatic fibrosis induced by dimethylnitrosamine in the fibrosis and/or cirrhosis by assaying the differential expres rat.” Biochem. J., 244:75-79 (1987). sion of proteins encoded by SEQID NO: 1-SEQ ID NO: 63 Rosenberg, William M. C., et al., "Serum markers detect the presence and human orthologs thereof. of liver fibrosis: A cohort study.” Gastroenterology, 127:1704-1713 (2004). 3 Claims, 8 Drawing Sheets US 7,972,785 B2 Page 2 OTHER PUBLICATIONS Mirsalis, J.C., and Butterworth, B.E., "Detection of unscheduled Haggerty, H.G. and Holsapple, M.P., “Role of metabolism in DNA synthesis in hepatocytes isolated from rats treated with dimethylnitrosamine-induced immunosuppression: a review.” genotoxic agents: an in vivo invitro assay for potential carcinogens and mutagens.” Carcinogenesis 1:621-624 (1980). Toxicol. 63:1-23 (1990). Morgan, C.L., Newman, D.J., Burrin, J.M., and Price, C.P. "The Hayaska, A. and Saisho, H., "Serum markers as tools to monitor liver matrix effects on kinetic rate constants of antibody-antigen interac fibrosis.” Digestion 59:381-384 (1998). tions reflect solvent viscosity.” J. Immunol. Meth. 217:51-60 (1998). Hernández-Munoz, R., et al., “Adenosine reverses a preestablished Neubauer, K., et al., "Accumulation and cellular localization of CC1-induced micronodular cirrhosis through enhancing col fibrinogen/fibrin during short-term and long-term rat liver injury.” lagenolytic activity and stimulating hepatocyte cell proliferation in Gastroenterol. 108:1124-1135 (1995). rats.” Hepatol. 34:677-687 (2001). Nielsen, P.E., et al., “Sequence-selective recognition of DNA by Hippo. Y., et al., “Global gene expression analysis of gastric cancer by Strand displacement with a thymine-substituted polyamide.” Science. 254(5037): 1497-1500 (1991). oligonucleotide microarrays.” Cancer Res.62:233-240 (2002). Okita, K., et al., “Current strategies for chemoprevention of Iizuka, N., et al., “Differential gene expression in distinct virologic hepatocellular carcinoma.” Oncology 62 (Suppl. 1):24-28 (2002). types of hepatocellular carcinoma: association with liver cirrhosis.” Sambrook et al., Molecular Cloning. A Laboratory Manual, vol. 3, Oncogene 22:3007-3014 (2003). pp. A8.40-A8.45 and A8.52-A8.55 (3d ed., Cold Spring Harbor Iredale, J.P., “Cirrhosis: new research provides a basis for rational Laboratory Press, Cold Spring Harbor, New York 2001). and targeted treatments.” BMJ 327:143-147 (2003). Schuppan, D., et al., “Hepatitis C and liver fibrosis.” Cell Death Iredale, J.P. "Tissue inhibitors of metalloproteinases in liver fibro Differ. 10:S59-67 (2003). sis.” Int. J. Biochem. Cell Biol. 29(1):43-54 (1997). Seth, D., et al., “Gene expression profiling of alcoholic liver disease Ishak, K., et al., “Histological grading and staging of chronic hepa in the baboon (Papio hamadryas) and human liver.” Am. J. Pathol. titis.” J. Hepatol. 22:696-699 (1995). 163(6):2303-2317 (2003). Jézequel, A.M., et al., "A morphological study of the early stages of Strauss, W.M., "Hybridization With Radioactive Probes.” in Current hepatic fibrosis induced by low doses of dimethylnitrosamine in the Protocols in Molecular Biology 6.3.1-6.3.6. (John Wiley & Sons, rat.” J. Hepatol. 5:174-181 (1987). N.Y. 2000). Ji, J., et al., “Comprehensive analysis of the gene expression profiles Waring, J.F., et al., “Microarray analysis of hepatotoxins in vitro in human gastric cancer cell lines.” Oncogene 21:6549-6556 (2002). reveals a correlation between gene expression profiles and mecha Knodell, R.G., et al., “Formulation and application of a numerical nisms of toxicity.” Toxicol. Letts. 120:359-368 (2001). scoring system for assessing histological activity in asymptomatic Waring, J.F., et al., "Clustering of hepatotoxins based on mechanism chronic active hepatitis.” Hepatol. 1(5):431-435 (1981). of toxicity using gene expression profiles. Toxicol. Appl. Pharmacol. López-De León, A. and Rojkind, M., “A simple micromethod for 175:28-42 (2001). collagen and total protein determination in formalin-fixed paraffin Wright, M.E., et al., “Mass spectrometry-based expression profiling embedded sections.”.J. Histochem. Cytochem. 33(8):737-743 (1985). of clinical prostate cancer.” Mol. Cell. Proteomics 44:545-554 Marvanová, M., et al., “Microarray analysis of nonhuman primates: (2005). validation of experimental models in neurological disorders.” FASEB Zhuang, G., et al., “Measurement of Association Rate Constant of J. 17:929-931 (2003). Antibody-Antigen Interactions in Solution Based on Enzyme-Linked MaZZocca, A., et al., “Expression of transmembrane 4 Superfamily Immunosorbent Assay.” J. Biosci. Bioeng. 92(4):330-336 (2001). (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration.” J.
Load more

Recommended publications
  • A Disease Spectrum for ITPA Variation: Advances in Biochemical and Clinical Research Nicholas E
    Burgis Journal of Biomedical Science (2016) 23:73 DOI 10.1186/s12929-016-0291-y REVIEW Open Access A disease spectrum for ITPA variation: advances in biochemical and clinical research Nicholas E. Burgis Abstract Human ITPase (encoded by the ITPA gene) is a protective enzyme which acts to exclude noncanonical (deoxy) nucleoside triphosphates ((d)NTPs) such as (deoxy)inosine 5′-triphosphate ((d)ITP), from (d)NTP pools. Until the last few years, the importance of ITPase in human health and disease has been enigmatic. In 2009, an article was published demonstrating that ITPase deficiency in mice is lethal. All homozygous null offspring died before weaning as a result of cardiomyopathy due to a defect in the maintenance of quality ATP pools. More recently, a whole exome sequencing project revealed that very rare, severe human ITPA mutation results in early infantile encephalopathy and death. It has been estimated that nearly one third of the human population has an ITPA status which is associated with decreased ITPase activity. ITPA status has been linked to altered outcomes for patients undergoing thiopurine or ribavirin therapy. Thiopurine therapy can be toxic for patients with ITPA polymorphism, however, ITPA polymorphism is associated with improved outcomes for patients undergoing ribavirin treatment. ITPA polymorphism has also been linked to early-onset tuberculosis susceptibility. These data suggest a spectrum of ITPA-related disease exists in human populations. Potentially, ITPA status may affect a large number of patient outcomes, suggesting that modulation of ITPase activity is an important emerging avenue for reducing the number of negative outcomes for ITPA-related disease.
    [Show full text]
  • Original Article Identification of B Cells Participated in the Mechanism of Postmenopausal Women Osteoporosis Using Microarray Analysis
    Int J Clin Exp Med 2015;8(1):1027-1034 www.ijcem.com /ISSN:1940-5901/IJCEM0003564 Original Article Identification of B cells participated in the mechanism of postmenopausal women osteoporosis using microarray analysis Bing Yan*, Jie Li*, Li Zhang Department of Orthopedics, Shandong Provincial Traditional Chinise Medical Hospital, Jinan 250014, Shandong Province, China. *Equal contributors. Received November 3, 2014; Accepted January 7, 2015; Epub January 15, 2015; Published January 30, 2015 Abstract: To further understand the molecular mechanism of lymphocytes B cells in postmenopausal women os- teoporosis. Microarray data (GSE7429) were downloaded from Gene Expression Omnibus, in which B cells were separated from the whole blood of postmenopausal women, including 10 with high bone mineral density (BMD) and 10 with low BMD. Differentially expressed genes (DEGs) between high and low BMD women were identified by Student’s t-test, and P < 0.01 was used as the significant criterion. Functional enrichment analysis was performed for up- and down-regulated DEGs using KEGG, REACTOME, and Gene Ontology (GO) databases. Protein-protein inter- action network (PPI) of up- and down-regulated DEGs was respectively constructed by Cytoscape software using the STRING data. Total of 169 up-regulated and 69 down-regulated DEGs were identified. Functional enrichment analy- sis indicated that the genes (ITPA, ATIC, UMPS, HPRT1, COX10 and COX15) might participate in metabolic pathways, MAP3K10 and MAP3K9 might participate in the activation of JNKK activity, COX10 and COX15 might involve in mitochondrial electron transport, and ATIC, UMPS and HPRT1 might involve in transferase activity. MAPK3, ITPA, ATIC, UMPS and HPRT1 with a higher degree in PPI network were identified.
    [Show full text]
  • Sheep Gene Mapping by Somatic Cell Hybridization
    Sheep gene mapping by somatic cell hybridization N Saïdi-Mehtar M Imam-Ghali1 S Heuertz2 MC Hors-Cayla2 1 Université d’Oran Es-Sénia, Laboratoire de Biologie M oléculaire et Génétique, Unite de Recherches de Biologie, Algeria; z 2 INSERM U12, Unit6 de Recherches de Genetique M6dicale, Paris, France (Proceedings of the 9th European Colloquium on Cytogenetics of Domestic Animals; Toulouse-Auzeville, 10-13 July 1990) sheep / ovine / gene mapping / synteny / cell hybrid INTRODUCTION Twenty-five hamster x sheep hybrid cell lines were previously obtained (Saidi- Mehtar et al, 1981b). Analysis of these hybrids has already enabled the identification of 5 syntenic groups and 10 independent markers (Saidi-Mehtar et al, 1981a, b, 1987; Millot et al, 1981; Imam-Ghali et al, 1987). In this paper, we report results obtained with 3 other enzyme markers: aconitase 1 (AC01), inosine triphosphatase (ITPA) and glyceraldehyde-3-phosphate dehydrogenase (GAPD); and 6 DNA markers: ornithine transcarbamylase (OTC), color vision red pigment (RCB), raf oncogene (ARAF1) and /3-gene locus DR of human lymphocyte antigen region (HLA-DR!). ENZYME MARKERS AC01, ITPA and GAPD were studied by cellulose acetate electrophoresis using modified versions of the methods described by Womack and Moll (1986). The cytoplasmic (AC01) and mitochondrial (AC02) forms of aconitase were identified by successive freezing and thawing of cells followed by electrophoresis of the supernatants. AC01 was obtained first and corresponded to the most anodal band. A different electrophoretic migration between sheep and hamster was only observed for ACO1. Ovine ITPA migrated more anodally than hamster ITPA. Ovine GAPD is a trimeric enzyme: positive hybrids for sheep GAPD showed 2 intermediate bands (fig 1).
    [Show full text]
  • Inosine Triphosphate Pyrophosphatase (ITPA) (NM 181493) Human Tagged ORF Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC215516L4 Inosine triphosphate pyrophosphatase (ITPA) (NM_181493) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: Inosine triphosphate pyrophosphatase (ITPA) (NM_181493) Human Tagged ORF Clone Tag: mGFP Symbol: ITPA Synonyms: C20orf37; DEE35; dJ794I6.3; HLC14-06-P; ITPase; My049; NTPase Vector: pLenti-C-mGFP-P2A-Puro (PS100093) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: Puromycin ORF Nucleotide The ORF insert of this clone is exactly the same as(RC215516). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_181493 ORF Size: 531 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 Inosine triphosphate pyrophosphatase (ITPA) (NM_181493) Human Tagged ORF Clone – RC215516L4 OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_181493.1 RefSeq Size: 1155 bp RefSeq ORF: 534 bp Locus ID: 3704 UniProt ID: Q9BY32 Protein Families: Druggable Genome Protein Pathways: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism, Pyrimidine metabolism MW: 19.4 kDa Gene Summary: This gene encodes an inosine triphosphate pyrophosphohydrolase.
    [Show full text]
  • A Realtime and Handson Research Course in Protein
    Q 2011 by The International Union of Biochemistry and Molecular Biology BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION Vol. 39, No. 1, pp. 28–37, 2011 Special Section: Innovative Laboratory Exercises A Real-time and Hands-on Research Course in Protein Purification and Characterization*,y,‡ PURIFICATION AND CRYSTAL GROWTH OF HUMAN INOSINE TRIPHOSPHATE PYROPHOSPHATASE Received for publication, March 19, 2010, and in revised form, June 7, 2010 Jodi L. Kreiling§**, Kerry Brader¶, Carol Kolar¶, and Gloria E. O. Borgstahl¶ From the §Department of Chemistry, University of Nebraska at Omaha, Omaha, Nebraska 68182, ¶Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska 68198 A new lecture/laboratory course to offer advanced biochemical training for undergraduate and early graduate students has been developed in the Department of Chemistry at the University of Nebraska at Omaha. This unique course offers students an opportunity to work hands-on with modern instrumentation not normally found in a predominately undergraduate institution, and to complete an entire research project in a realistic timeframe via a time-intensive curriculum as a special summer session. The course content gives a strong background in protein structure/chemistry, purification principles, protocol development, optimization strategies, use and pro- gramming of an automated chromatography instrument, and characterization strategies with an emphasis on X-ray crystallography. The laboratory portion offers students the chance to purify a protein (human inosine tri- phosphate pyrophosphatase) from start to finish, program and use an A¨ KTA fast protein liquid chromatography instrument, and to grow and analyze their own protein crystals using their purified protein.
    [Show full text]
  • Pharmacogenomics of Ventricular Conduction in Multi-Ethnic Populations Amanda Seyerle Dissertation Committee
    Pharmacogenomics of Ventricular Conduction in Multi-Ethnic Populations Amanda Seyerle Dissertation Committee: Christy Avery (chair) Kari North Eric Whitsel Til Stürmer Craig Lee 1 TABLE OF CONTENTS Page LIST OF TABLES ...................................................................................................................................... v LIST OF FIGURES ..................................................................................................................................... vi LIST OF ABBREVIATIONS ..................................................................................................................... vii LIST OF GENE NAMES ............................................................................................................................ ix 1. Overview .............................................................................................................................................. 1 2. Specific Aims ....................................................................................................................................... 3 3. Background and Significance ............................................................................................................ 4 A. Ventricular Conduction ......................................................................................................................... 4 A.1. Electrical Conduction of the Heart ................................................................................................ 4 A.1.1. Sodium Channels..................................................................................................................
    [Show full text]
  • Investigating Developmental and Epileptic Encephalopathy Using Drosophila Melanogaster
    International Journal of Molecular Sciences Review Investigating Developmental and Epileptic Encephalopathy Using Drosophila melanogaster Akari Takai 1 , Masamitsu Yamaguchi 2,3, Hideki Yoshida 2 and Tomohiro Chiyonobu 1,* 1 Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan; [email protected] 2 Department of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 603-8585, Japan; [email protected] (M.Y.); [email protected] (H.Y.) 3 Kansai Gakken Laboratory, Kankyo Eisei Yakuhin Co. Ltd., Kyoto 619-0237, Japan * Correspondence: [email protected] Received: 15 August 2020; Accepted: 1 September 2020; Published: 3 September 2020 Abstract: Developmental and epileptic encephalopathies (DEEs) are the spectrum of severe epilepsies characterized by early-onset, refractory seizures occurring in the context of developmental regression or plateauing. Early infantile epileptic encephalopathy (EIEE) is one of the earliest forms of DEE, manifesting as frequent epileptic spasms and characteristic electroencephalogram findings in early infancy. In recent years, next-generation sequencing approaches have identified a number of monogenic determinants underlying DEE. In the case of EIEE, 85 genes have been registered in Online Mendelian Inheritance in Man as causative genes. Model organisms are indispensable tools for understanding the in vivo roles of the newly identified causative genes. In this review, we first present an overview of epilepsy and its genetic etiology, especially focusing on EIEE and then briefly summarize epilepsy research using animal and patient-derived induced pluripotent stem cell (iPSC) models. The Drosophila model, which is characterized by easy gene manipulation, a short generation time, low cost and fewer ethical restrictions when designing experiments, is optimal for understanding the genetics of DEE.
    [Show full text]
  • Table S1. 103 Ferroptosis-Related Genes Retrieved from the Genecards
    Table S1. 103 ferroptosis-related genes retrieved from the GeneCards. Gene Symbol Description Category GPX4 Glutathione Peroxidase 4 Protein Coding AIFM2 Apoptosis Inducing Factor Mitochondria Associated 2 Protein Coding TP53 Tumor Protein P53 Protein Coding ACSL4 Acyl-CoA Synthetase Long Chain Family Member 4 Protein Coding SLC7A11 Solute Carrier Family 7 Member 11 Protein Coding VDAC2 Voltage Dependent Anion Channel 2 Protein Coding VDAC3 Voltage Dependent Anion Channel 3 Protein Coding ATG5 Autophagy Related 5 Protein Coding ATG7 Autophagy Related 7 Protein Coding NCOA4 Nuclear Receptor Coactivator 4 Protein Coding HMOX1 Heme Oxygenase 1 Protein Coding SLC3A2 Solute Carrier Family 3 Member 2 Protein Coding ALOX15 Arachidonate 15-Lipoxygenase Protein Coding BECN1 Beclin 1 Protein Coding PRKAA1 Protein Kinase AMP-Activated Catalytic Subunit Alpha 1 Protein Coding SAT1 Spermidine/Spermine N1-Acetyltransferase 1 Protein Coding NF2 Neurofibromin 2 Protein Coding YAP1 Yes1 Associated Transcriptional Regulator Protein Coding FTH1 Ferritin Heavy Chain 1 Protein Coding TF Transferrin Protein Coding TFRC Transferrin Receptor Protein Coding FTL Ferritin Light Chain Protein Coding CYBB Cytochrome B-245 Beta Chain Protein Coding GSS Glutathione Synthetase Protein Coding CP Ceruloplasmin Protein Coding PRNP Prion Protein Protein Coding SLC11A2 Solute Carrier Family 11 Member 2 Protein Coding SLC40A1 Solute Carrier Family 40 Member 1 Protein Coding STEAP3 STEAP3 Metalloreductase Protein Coding ACSL1 Acyl-CoA Synthetase Long Chain Family Member 1 Protein
    [Show full text]
  • Atlas Journal
    Atlas of Genetics and Cytogenetics in Oncology and Haematology Home Genes Leukemias Solid Tumours Cancer-Prone Deep Insight Portal Teaching X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA Atlas Journal Atlas Journal versus Atlas Database: the accumulation of the issues of the Journal constitutes the body of the Database/Text-Book. TABLE OF CONTENTS Volume 11, Number 3, Jul-Sep 2007 Previous Issue / Next Issue Genes MSH6 (mutS homolog 6 (E. Coli)) (2p16). Sreeparna Banerjee. Atlas Genet Cytogenet Oncol Haematol 2006; 9 11 (3): 289-297. [Full Text] [PDF] URL : http://atlasgeneticsoncology.org/Genes/MSH6ID344ch2p16.html LDB1 (10q24). Takeshi Setogawa, Testu Akiyama. Atlas Genet Cytogenet Oncol Haematol 2006; 11 (3): 298-301.[Full Text] [PDF] URL : http://atlasgeneticsoncology.org/Genes/LDB1ID41135ch10q24.html INTS6 (integrator complex subunit 6) (13q14.3). Ilse Wieland. Atlas Genet Cytogenet Oncol Haematol 2006; 11 (3): 302-306.[Full Text] [PDF] URL : http://atlasgeneticsoncology.org/Genes/INTS6ID40287ch13q14.html EPHA7 (EPH receptor A7) (6q16.1). Haruhiko Sugimura, Hiroki Mori, Tomoyasu Bunai, Masaya Suzuki. Atlas Genet Cytogenet Oncol Haematol 2007; 11 (3): 307-312. [Full Text] [PDF] Atlas Genet Cytogenet Oncol Haematol 2007;3 -I URL : http://atlasgeneticsoncology.org/Genes/EPHA7ID40466ch6q16.html RNASET2 (ribonuclease T2) (6q27). Francesco Acquati, Paola Campomenosi. Atlas Genet Cytogenet Oncol Haematol 2007; 11 (3): 313-317. [Full Text] [PDF] URL : http://atlasgeneticsoncology.org/Genes/RNASET2ID518ch6q27.html RHOB (ras homolog gene family, member B) (2p24.1). Minzhou Huang, Lisa D Laury-Kleintop, George Prendergast. Atlas Genet Cytogenet Oncol Haematol 2007; 11 (3): 318-323.
    [Show full text]
  • Comparative Gene Mapping in the Domestic Cat (Felis Catus)
    Comparative Gene Mapping in the Domestic Cat (Felis catus) S. J. O'Brien, S. J. Cevario, J. S. Martenson, M. A. Thompson, W. G. Nash, E. Chang, J. A. M. Graves, J. A. Spencer, K.-W. Cho, H. Tsujimoto, and L. A. Lyons The genetic map of the domestic cat has been developed as a model for studying Downloaded from both feline analogues of human genetic disease and comparative genome organi- zation of mammals. We present here the results of syntenic mapping of 35 genes based upon concordant occurrence of feline gene homologues with feline chro- mosomes and previously mapped loci in a panel of 41 rodent x cat somatic cell hybrids. These somatic cell hybrids retain rodent chromosomes and segregate fe- http://jhered.oxfordjournals.org/ line chromosomes, but in different combinations in each hybrid cell line. Thirty- three of the 35 new locus assignments extend and reaffirm conserved chromosome segment homologies between the human and cat genomes previously recognized by comparative mapping and zoo-FISH. These results demonstrate the extensive syntenic conservation between the human and feline genomes and extend the fe- line gene map to Include 105 assigned loci. Genetic mapping of homologous loci in di- ical comparisons (Lyons et aJ. 1994, 1997; verse species reveals that genomic orga- Nash and O'Brien 1982, O'Brien and Nash nization is not a random process (Com- 1982; O'Brien et al. 1993, 1997). More re- at University of California, Davis - Library on September 12, 2012 parative Genome Organization 1996; Co- cently, reciprocal chromosome painting peland et al. 1993; DeBry and Seldin 1996; using individual probes from flow-sorted Nadeau et al.
    [Show full text]
  • Itpase-Deficient Mice Show Growth Retardation and Die Before Weaning
    Cell Death and Differentiation (2009) 16, 1315–1322 & 2009 Macmillan Publishers Limited All rights reserved 1350-9047/09 $32.00 www.nature.com/cdd ITPase-deficient mice show growth retardation and die before weaning M Behmanesh1,2, K Sakumi*,1, N Abolhassani1, S Toyokuni3, S Oka1, YN Ohnishi1, D Tsuchimoto1 and Y Nakabeppu1 Inosine triphosphate pyrophosphatase (ITPase), the enzyme that hydrolyzes ITP and other deaminated purine nucleoside triphosphates to the corresponding purine nucleoside monophosphate and pyrophosphate, is encoded by the Itpa gene. In this study, we established Itpa knockout (KO) mice and used them to show that ITPase is required for the normal organization of sarcomeres in the heart. ItpaÀ/À mice died about 2 weeks after birth with features of growth retardation and cardiac myofiber disarray, similar to the phenotype of the cardiac a-actin KO mouse. Inosine nucleotides were found to accumulate in both the nucleotide pool and RNA of ItpaÀ/À mice. These data suggest that the role of ITPase in mice is to exclude ITP from the ATP pool, and the main target substrate of this enzyme is rITP. Our data also suggest that cardiomyopathy, which is mainly caused by mutations in sarcomeric protein-encoding genes, is also caused by a defect in maintaining the quality of the ATP pool, which is an essential requirement for sarcomere function. Cell Death and Differentiation (2009) 16, 1315–1322; doi:10.1038/cdd.2009.53; published online 5 June 2009 Nucleotide and polynucleotide molecules are spontaneously repair of alkylation-induced DNA damage, and increased damaged under the physiological conditions.1–3 These sensitivity to methyl methanesulfonate and streptozotocin- modifications often cause a nucleotide to pair with an alternate induced diabetes.20,21 However, there is no report regarding partner nucleotide in DNA.4,5 For example, 8-oxo-dGTP, an ITPase and endonuclease V knockout mouse as yet.
    [Show full text]
  • HCV) Antiviral Response in a Multiethnic and Admixed Population
    The Pharmacogenomics Journal (2014) 14, 549–554 & 2014 Macmillan Publishers Limited All rights reserved 1470-269X/14 www.nature.com/tpj ORIGINAL ARTICLE Distribution of genetic polymorphisms associated with hepatitis C virus (HCV) antiviral response in a multiethnic and admixed population J Trinks1,2, ML Hulaniuk1, M Caputo3,2, L Burgos Pratx4,VRe´ 5,2, L Fortuny4, A Pontoriero1,AFrı´as6, O Torres6, F Nun˜ez4, A Gadano7,D Corach3,2 and D Flichman8,2 The prevalence of genetic polymorphisms identified as predictors of therapeutic-induced hepatitis C virus (HCV) clearance differs among ethnic groups. However, there is a paucity of information about their prevalence in South American populations, whose genetic background is highly admixed. Hence, single-nucleotide polymorphisms rs12979860, rs1127354 and rs7270101 were characterized in 1350 healthy individuals, and ethnicity was assessed in 259 randomly selected samples. The frequency of rs12979860CC, associated with HCV treatment response, and rs1127354nonCC, related to protection against hemolytic anemia, were significantly higher among individuals with maternal and paternal Non-native American haplogroups (64.5% and 24.2%), intermediate among admixed samples (44.1% and 20.4%) and the lowest for individuals with Native American ancestry (30.4% and 6.5%). This is the first systematic study focused on analyzing HCV predictors of antiviral response and ethnicity in South American populations. The characterization of these variants is critical to evaluate the risk–benefit of antiviral treatment
    [Show full text]